Bulletin
Investor Alert

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205657894/composite

$

8.76

Change

-0.07 -0.79%

Volume

Volume 32,426

Oct 4, 2022, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205657894/composite

Today's close

$ 8.23

$ 8.83

Change

+0.60 +7.29%

Day low

Day high

$8.38

$8.83

Open
Open: 8.40

52 week low

52 week high

$6.78

$11.34

Open

Market cap

$9.22B

Average volume

13.94M

P/E ratio

N/A

Rev. per Employee

$410,182

EPS

-0.95

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/teva

MarketWatch News on TEVA

  1. Teva Pharmaceutical upgraded to buy from neutral at BofA Securities

    9:44 a.m. Aug. 5, 2022

    - Tomi Kilgore

  2. $4.4 Billion Opioid Settlement Gives Teva Stock a Boost

    3:32 a.m. July 28, 2022

    - Barron's Online

  3. Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement

    6:14 a.m. July 27, 2022

    - Barron's Online

  4. Teva to pay $75 mln over 15 years to settle opioid claims from W. Va., plus pay $8 mln in legal fees

    9:46 a.m. May 25, 2022

    - Steve Gelsi

  5. Teva settlement with W. Va. also includes $27 mln worth of generic Narcan over 10 years

    9:46 a.m. May 25, 2022

    - Steve Gelsi

  6. W. Va. says Teva opioid agreement consistent with previously announced settlements

    9:46 a.m. May 25, 2022

    - Steve Gelsi

  7. Teva Pharmaceutical upgraded to neutral from underperform at BofA Securities

    9:36 a.m. May 17, 2022

    - Tomi Kilgore

  8. Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion

    10:06 a.m. May 10, 2022

    - Barron's Online

  9. Teva CEO Sees a Final Opioid Settlement Coming This Year

    4:58 p.m. May 3, 2022

    - Barron's Online

  10. Teva now sees full-year revenue of $15.4 bln to $16.0 bln vs. prior guidance of $15.6 bln to $16.2 bln

    7:19 a.m. May 3, 2022

    - Ciara Linnane

  11. Teva now sees full-year EPS of $2.40 to $2.60, unchanged vs. prior guidance

    7:20 a.m. May 3, 2022

    - Ciara Linnane

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/teva

Other News on TEVA

  1. Teva to pay Georgia ~$3.35M to settle price-fixing claims

    8:56 a.m. Sept. 30, 2022

    - Seeking Alpha

  2. Teva to finalize opioid deal by year-end – CEO

    6:24 a.m. Sept. 19, 2022

    - Seeking Alpha

  3. Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike

    4:21 a.m. Sept. 18, 2022

    - Seeking Alpha

  4. Teva Pharmaceutical: Past Behind And A Promising 2023

    6:00 p.m. Sept. 16, 2022

    - Seeking Alpha

  5. Adderall Shortages Push ADHD Patients to Make Adjustments

    5:04 p.m. Sept. 16, 2022

    - Joseph De Avila

  6. Exelixis, Teva fight over Cabometyx generic again

    9:01 a.m. Sept. 6, 2022

    - Seeking Alpha

  7. Viatris: 5% Dividend Yield Is A Threat For Investors

    10:36 p.m. Sept. 5, 2022

    - Seeking Alpha

  8. Sanofi, GSK gains as Citi sees limited impact from Zantac claims

    10:12 a.m. Aug. 26, 2022

    - Seeking Alpha

  9. Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision

    10:05 a.m. Aug. 15, 2022

    - Zacks.com

  10. Loading more headlines...
/news/pressrelease/company/us/teva

Press Releases on TEVA

  1. Teva Pharmaceutical (TEVA) Trading Report

    5:31 p.m. Sept. 29, 2022

    - Stock Traders Daily

  2. How To Trade Teva Pharmaceutical TEVA

    11:12 p.m. Sept. 19, 2022

    - Stock Traders Daily

  3. Teva Pharmaceutical TEVA Investment Report

    6:14 a.m. Sept. 10, 2022

    - Stock Traders Daily

  4. Teva Pharmaceutical TEVA Trading Report

    1:56 p.m. Aug. 31, 2022

    - Stock Traders Daily

  5. Teva Pharmaceutical TEVA Investment Analysis and Advice

    8:55 p.m. Aug. 21, 2022

    - Stock Traders Daily

  6. Teva Pharmaceutical (TEVA) Trading Report

    4:21 a.m. Aug. 12, 2022

    - Stock Traders Daily

  7. Thursday's ETF with Unusual Volume: HEFA

    12:42 p.m. Aug. 11, 2022

    - MarketNewsVideo.com

  8. How To Trade Invalid Iqfeed Symbol TEVA

    11:02 a.m. Aug. 2, 2022

    - Stock Traders Daily

  9. Teva Reports Second Quarter 2022 Financial Results

    4:55 p.m. July 26, 2022

    - BusinessWire - BZX

  10. Certara Appoints Rosemary Crane as New Independent Board Member

    8:00 a.m. July 25, 2022

    - GlobeNewswire

  11. Teva Pharmaceutical (TEVA) Trading Report

    7:56 p.m. July 23, 2022

    - Stock Traders Daily

  12. Loading more headlines...

Rates »

Link to MarketWatch's Slice.